Submitted by Diane Farsetta on
Johnson & Johnson's biopharmaceutical unit, Centocor, "has developed a documentary film to serve as the centerpiece of a national campaign," reports O'Dwyer's. The movie, "Innerstate," follows "three patients living with chronic diseases like Crohn's disease, Rheumatoid arthritis, and psoriasis -- ailments for which Centocor markets treatments.
Submitted by Bob Burton on
Submitted by Diane Farsetta on
Submitted by Diane Farsetta on
The House Committee on Oversight and Government Reform is holding hearings on "waste, fraud, and abuse of taxpayer dollars"; topics include Iraq reconstruction, Homeland Security contracting, and prescription drug pricing. Companies called to testify are "scrambling to hire lobbyists with Democratic ties," reports Bloomberg.
Submitted by Diane Farsetta on
A new study "funded by the Robert Wood Johnson Foundation and published in the Jan. 29 Annals of Family Medicine, claims the $4.5 billion" direct-to-consumer drug ad (DTC) industry "produces ads that are more emotional than informational, and may be convincing Americans that they're sicker than they really are," reports Advertising Age.
Submitted by Jonathan Rosenblum on
A University of Pittsburgh child psychiatrist who conducted company-sponsored clinical trials on adolescent use of the antidepressant Paxil also conferred with the company on how to respond to press inquiries challenging the safety of the drug for adolescents, reports the BBC investigative program, Panorama. The psychiatrist, Dr. Neal Ryan, sent emails to GlaxoSmithKline dating to 2002 requesting media advice.
Submitted by Bob Burton on
Submitted by Bob Burton on
The $4 billion a year spent by the drug industry on direct-to-consumer advertising promoting drugs is generating a political backlash. "There's a lot of support for a ban on direct-to-consumer advertising, and the Democrats know it," said Gary Ruskin, Commercial Alert's executive director.
Submitted by Bob Burton on
A U.S. federal court judge has extended an injunction banning groups in the U.S. from adding a weblink to leaked internal documents on Eli Lilly's schizophrenia and bipolar disorder drug, Zyprexa.
Submitted by Bob Burton on
Medical researchers at George Washington University have launched a new website, PharmedOut, which is designed to help doctors "identify and counter inappropriate pharmaceutical promotion practices." It also provides links to over 100 continuing medical education (CME) courses that have been developed without drug industry funding.
Center for Media and Democracy (CMD)
520 University Ave, Ste 305 • Madison, WI 53703 • (608) 260-9713
CMD is a 501(c)(3) tax-exempt non-profit.
© 1993-2024